The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
EFNS guideline on the treatment of cerebral venous and sinus thrombosis
Open accessAbstract
Cerebral venous and sinus thrombosis (CVST) is a rather rare disease which accounts for <1% of all strokes. Diagnosis is still frequently overlooked or delayed due to the wide spectrum of clinical symptoms and the often subacute or lingering onset. Current therapeutic measures which are used in clinical practice include the use of anticoagulants such as dose‐adjusted intravenous heparin or body weight‐adjusted subcutaneous low‐molecular‐weight heparin (LMWH), the use of thrombolysis, and symptomatic therapy including control of seizures and elevated intracranial pressure. We searched MEDLINE (National Library of Medicine), the Cochrane Central Register of Controlled Trials (CENTRAL) and the Cochrane Library to review the strength of evidence to support these interventions and the preparation of recommendations on the therapy of CVST based on the best available evidence. Review articles and book chapters were also included. Recommendations were reached by consensus. Where there was a lack of evidence, but consensus was clear we stated our opinion as good practice points. Patients with CVST without contraindications for anticoagulation should be treated either with body weight‐adjusted subcutaneous LMWH or dose‐adjusted intravenous heparin (good practice point). Concomitant intracranial haemorrhage related to CVST is not a contraindication for heparin therapy. The optimal duration of oral anticoagulation after the acute phase is unclear. Oral anticoagulation may be given for 3 months if CVST was secondary to a transient risk factor, for 6–12 months in patients with idiopathic CVST and in those with ‘mild’ hereditary thrombophilia. Indefinite anticoagulation (AC) should be considered in patients with two or more episodes of CVST and in those with one episode of CVST and ‘severe’ hereditary thrombophilia (good practice point). There is insufficient evidence to support the use of either systemic or local thrombolysis in patients with CVST. If patients deteriorate despite adequate anticoagulation and other causes of deterioration have been ruled out, thrombolysis may be a therapeutic option in selected cases, possibly in those without intracranial haemorrhage (good practice point). There are no controlled data about the risks and benefits of certain therapeutic measures to reduce an elevated intracranial pressure (with brain displacement) in patients with severe CVST. Antioedema treatment (including hyperventilation, osmotic diuretics and craniectomy) should be used as life saving interventions (good practice point).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferro, J. M., Canhão, P., Stam, J., Bousser, M.-G., & Barinagarrementeria, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,315
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249 · cited 2×
“Indefinite AC is also recommended in patients with two or more episodes of idiopathic objectively documented extracerebral venous thrombosis [23].”
BackgroundCerebral Sinovenous Thrombosis in Children
deVeber, G., Andrew, M., Adams, C., Bjornson, B., Booth, F., Buckley, D. J., Camfield, C. S., David, M., Humphreys, P., Langevin, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450604 · Cited by 1,139
Heparin treatment in sinus venous thrombosis
Einhäupl, K. M., Villringer, A., Mehraein, S., Garner, C., Pellkofer, M., Haberl, R. L., Pfister, H.-W., Schmiedek, P., & Meister, W. (1991) · The Lancet · doi:10.1016/0140-6736(91)90607-q · Cited by 992
Self-citationde Bruijn, S. F. T. M., & Stam, J. (1999) · Stroke · doi:10.1161/01.str.30.3.484 · Cited by 817
Self-citationAmeri, A., & Bousser, M.-G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30235-4 · Cited by 795
Self-citationCerebral venous thrombosis--a review of 38 cases.
Bousser, M. G., Chiras, J., Bories, J., & Castaigne, P. (1985) · Stroke · doi:10.1161/01.str.16.2.199 · Cited by 778
Self-citationvan Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
Long-term Prognosis in Cerebral Venous Thrombosis: Follow-up of 77 Patients
Preter, M., Tzourio, C., Ameri, A., & Bousser, M.-G. (1996) · Stroke · doi:10.1161/01.str.27.2.243 · Cited by 382
Self-citation
Cited by
Saposnik, G., Barinagarrementeria, F., Brown, R. D., Bushnell, C. D., Cucchiara, B., Cushman, M., deVeber, G., Ferro, J. M., & Tsai, F. Y. (2011) · Stroke · doi:10.1161/str.0b013e31820a8364 · Cited by 1,970
Self-citationAntithrombotic Therapy in Neonates and Children
Monagle, P., Chan, A. K. C., Goldenberg, N. A., Ichord, R. N., Journeycake, J. M., Nowak-Göttl, U., & Vesely, S. K. (2012) · Chest · doi:10.1378/chest.11-2308 · Cited by 1,491
Cerebral venous thrombosis: an update
Bousser, M.-G., & Ferro, J. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70029-7 · Cited by 1,229
Self-citationFerriero, D. M., Fullerton, H. J., Bernard, T. J., Billinghurst, L., Daniels, S. R., DeBaun, M. R., deVeber, G., Ichord, R. N., Jordan, L. C., Massicotte, P., et al. (2019) · Stroke · doi:10.1161/str.0000000000000183 · Cited by 797
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008) · Chest · doi:10.1378/chest.08-0762 · Cited by 676
Metadata
- Authors
- Einhäupl, K., Bousser, M. ‐., De Bruijn, S. F. T. M., Ferro, J. M., Martinelli, I., Masuhr, F., & Stam, J.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2006-06
- Volume
- 13
- Issue
- 6
- Pages
- 553-559
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2099965943
- Cited by
- 298
- References
- 23
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EFNS guideline on the treatment of cerebral venous and sinus thrombosis. https://app.cochat.ai/papers/10.1111/j.1468-1331.2006.01398.x
- The paper
- Einhäupl, K., Bousser, M. ‐., De Bruijn, S. F. T. M., Ferro, J. M., Martinelli, I., Masuhr, F., & Stam, J. (2006). EFNS guideline on the treatment of cerebral venous and sinus thrombosis. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2006.01398.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.